In re Metoprolol Succinate Direct Purchaser Antitrust Litigation, No. 06-52 (D. Del.)


In the Toprol case, Faruqi & Faruqi, LLP represents a pharmaceutical wholesaler and a class of direct purchasers of AstraZeneca’s branded drug Toprol XL (extended-release metoprolol succinate).  The case alleges that AstraZeneca fraudulently procured two patents and filed multiple baseless patent infringement lawsuits using those patents, solely in an effort to delay less-expensive generic competition, a violation of § 2 of the Sherman Act.  A $20 million settlement in the case has been approved by the court, and final judgment has been entered.

Send Information

If you have information regarding this case that you would like to make available, please click here to contact us about our investigation.

Details

Filed on 06/05/2006

Office

1617 JFK Boulevard, Suite 1550

19103 Philadelphia, Pennsylvania

Phone (215) 277-5770

Fax (215) 277-5771

Counsel

Peter Kohn pkohn@faruqilaw.com Phone (215) 277-5770 Fax (215) 277-5771

Finding us

Our Offices


Our offices are nationwide. If you have any questions about a case or our firm, please contact us.

New York

685 Third Avenue 26th Floor
New York, New York 10017
(212) 983-9330
(877) 247-4292
(212) 983-9331

California

10866 Wilshire Boulevard Suite 1470
Los Angeles, California 90024
(424) 256-2884
(424) 256-2885

Georgia

3565 Piedmont Road NE Building Four, Suite 380
Atlanta, Georgia 30305
(404) 847-0617
(404) 506-9534

Pennsylvania

1617 JFK Boulevard, Suite 1550
Philadelphia, Pennsylvania 19103
(215) 277-5770
(215) 277-5771

Faruqi & Faruqi office in New York, New York

Faruqi & Faruqi office in Los Angeles, California

Faruqi & Faruqi office in Atlanta, Georgia

Faruqi & Faruqi office in Philadelphia, Pennsylvania